IR vs SANA · P/E 49, rev $3.90B vs $846.0M cap
Ingersoll Rand Inc (IR) versus Sana Biotechnology Inc (SANA) — a side-by-side from cached financials, not a winner call.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Sana Biotechnology Inc (SANA) is a biotechnology company listed on NASDAQ.
Latest reported IR revenue for 2026-06-30 was $3.90B. Net income was $448.9M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
SANA does not have a complete income-statement cache yet.
IR currently screens at market cap $28.27B and trailing P/E 48.8. SANA currently screens at market cap $846.0M.
Not investment advice. Open the IR and SANA stock pages for the full models.
Not investment advice.